Cubist Systematic Strategies’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Cubist Systematic Strategies’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$3.62M	Buy	104,539 +92,168	+745%	+$2.95M	0.02%	1188
2025 Q2	$346K	Buy	+12,371	New	+$332K	﹤0.01%	2406
2024 Q2	–	Sell	-20,088	Closed	-$647K	–	3360
2024 Q1	$647K	Sell	20,088 -25,319	-56%	-$942K	﹤0.01%	2461
2023 Q4	$1.85M	Buy	45,407 +22,158	+95%	+$815K	0.01%	1585
2023 Q3	$803K	Buy	23,249 +23,228	+110,610%	+$904K	0.01%	2028
2023 Q2	$854	Sell	21 -17,194	-100%	-$701K	﹤0.01%	3370
2023 Q1	$665K	Buy	17,215 +16,296	+1,773%	+$670K	﹤0.01%	2488
2022 Q4	$40.8K	Sell	919 -2,239	-71%	-$94.2K	﹤0.01%	3930
2022 Q3	$135K	Sell	3,158 -37,969	-92%	-$1.95M	﹤0.01%	3916
2022 Q2	$2.29M	Sell	41,127 -4,718	-10%	-$280K	0.01%	1722
2022 Q1	$2.84M	Buy	45,845 +9,311	+25%	+$570K	0.02%	1201
2021 Q4	$2.01M	Sell	36,534 -5,189	-12%	-$271K	0.02%	1362
2021 Q3	$2.19M	Buy	41,723 +4,201	+11%	+$249K	0.03%	949
2021 Q2	$2.58M	Buy	37,522 +21,071	+128%	+$1.61M	0.03%	931
2021 Q1	$1.27M	Buy	16,451 +1,773	+12%	+$163K	0.02%	1377
2020 Q4	$1.45M	Buy	+14,678	New	+$1.79M	0.02%	1148
2020 Q2	–	Sell	-3,637	Closed	-$713K	–	2429
2020 Q1	$713K	Sell	3,637 -2,008	-36%	-$432K	0.02%	1038
2019 Q4	$1.17M	Buy	5,645 +3,576	+173%	+$661K	0.02%	1062
2019 Q3	$316K	Buy	2,069 +430	+26%	+$70.5K	0.01%	1530
2019 Q2	$211K	Buy	+1,639	New	+$194K	﹤0.01%	2020
2019 Q1	–	Sell	-4,282	Closed	-$393K	–	2304
2018 Q4	$393K	Buy	4,282 +709	+20%	+$71.9K	0.02%	1107
2018 Q3	$402K	Buy	+3,573	New	+$378K	0.02%	971
2017 Q4	–	Sell	-3,513	Closed	-$357K	–	1969
2017 Q3	$357K	Sell	3,513 -5,687	-62%	-$497K	0.02%	1042
2017 Q2	$704K	Buy	+9,200	New	+$774K	0.05%	584
2016 Q1	–	Sell	-3,946	Closed	-$248K	–	1694
2015 Q4	$248K	Buy	+3,946	New	+$202K	0.01%	1232

Other funds holding LKFT

Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

DCM

DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Cubist Systematic Strategies's LKFT Position: Q3 2025 in Review

Cubist Systematic Strategies increased its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 745% in Q3 2025, buying an estimated $2.95M and bringing the position to 104,539 shares worth $3.62M. The position accounts for 0.02% of the portfolio, ranked #1188.

Cubist Systematic Strategies first reported a position in LKFT in Q4 2015 and has held it in 25 quarters since. 92 funds tracked by Wall St. Rank hold LKFT as of Q3 2025.

Cubist Systematic Strategies held 104,539 shares of Lakefront Biotherapeutics American Depositary Shares worth $3.62M as of Q3 2025.
Cubist Systematic Strategies bought 92,168 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2025, an estimated $2.95M.
Lakefront Biotherapeutics American Depositary Shares made up 0.02% of Cubist Systematic Strategies's portfolio in Q3 2025, its #1188 holding.
Cubist Systematic Strategies first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2015 and has held it in 25 quarters since.
92 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.